Effect of prostaglandin E2 on the proliferation, Ca2+ mobilization and cAMP in HT-29 human colon adenocarcinoma cells

Cancer Letters

Volumn 152, Issue 2, 2000, Pages 217-222

  Cassano, Giuseppe ^a   Gasparre, Giuseppe ^a   Susca, Francesco ^a   Lippe, Claudio ^a   Guanti, Ginevra ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Colon cancer; NSAIDs; Prostaglandin H synthase 1; Prostaglondin H synthase 2; Prostanoids

Indexed keywords

17 PHENYLTRINORPROSTAGLANDIN E2; BOMBESIN; CYCLIC AMP; INDOMETACIN; ISOPRENALINE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; TUMOR CELL LINE;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BOMBESIN; CALCIUM; CELL DIVISION; COLONIC NEOPLASMS; CYCLIC AMP; DINOPROSTONE; HT29 CELLS; HUMANS; INDOMETHACIN; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 0034193670     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00339-6     Document Type: Article

References (27)

1. Levy G.N. Prostaglandin H synthases, non-steroidal antiinflammatory drugs, and colon cancer. FASEB J. 11:1997;234-247.
2. Lippman S.M., Lee J.J., Sabichi A.L. Cancer chemoprevention: progress and promise. J. Natl. Cancer Inst. 90:1998;1514-1528.
3. Taketo M.M. Cyclo-oxygenase-2 inhibitors in tumorigenesis (Part I). J. Natl. Cancer Inst. 90:1998;1529-1536.
4. Kargman S.L., O'Neill G.P., Vickers P.J., Evans J.F., Mancini J.A., Jothy S. Expression of prostaglandin G/H synthase-1 and-2 protein in human colon cancer. Cancer Res. 55:1995;2556-2559.
5. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., Taketo M.M. Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809.
6. Waddell W.R., Ganser G.F., Cerise E.J., Loughry R.W. Sulindac for polyposis of the colon. Am. J. Surg. 157:1989;175-179.
7. Earnest D.L., Hixson L.J., Alberts D.S. Piroxicam and other cyclooxygenase inhibitors: potential for cancer prevention. J. Cell. Biochem. (Suppl). 161:1992;156-160.
8. Rigas B., Goldman I.S., Levine L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122:1993;518-523.
9. Jacoby R.F., Marshall D.J., Newton M.A., Novakovic K., Tutsch K., Cole C.E., Lubet R.A., Kelloff G.J., Verma A., Moser A.R., Dove W.F. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the non-steroidal anti-inflammatory drug piroxicam. Cancer Res. 56:1996;710-714.
10. Boolbol S.K., Dannenberg A.J., Chadmburg A., Martucci C., Guo X.J., Ramonetti J.T., Abreu-Goris M., Newmark H.L., Lipkin M.L., DeCosse J.J., Bertagnolli M.M. Cyclooxygenase-2 over-expression and tumor formation are blocked by sulindac in murine model of familial adenomatous polyposis. Cancer Res. 56:1996;2556-2560.
11. Karmali R.A. Prostaglandin and cancer. CA Cancer J. Clin. 33:1983;322-332.
12. Tutton P.J., Barkla D.H. Influence of prostaglandin analogues on epithelial cell proliferation and xenograft growth. Br. J. Cancer. 41:1980;47-51.
13. Goodlab R., Mandir N., Levin S., Allen J.L., Wright N.A. Prostaglandin and the colonic epithelium. Effects of misoprostol on crypt size, cell production, and cell migration in the dog. Gastroenterology. 101:1991;1229-1234.
14. Santoro M.G., Philpott G.W., Jaffe B.M. Inhibition of tumor growth in vivo and in vitro by prostaglandin E. Nature. 263:1976;777-779.
15. Piazza G.A., Alberts D.S., Hixson L.J., Paranka N.S., Li H., Finn T., Bogert C., Guillen J.M., Brendel K., Gross P.H., Sperl G., Ritchie J., Burt R.W., Ellsworth L., Ahnen D.J., Pamukcu R. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res. 15:1997;2909-2915.
16. Hanif R., Pittas A., Feng Y., Koutsos M.I., Qiao L., Staiano-Coco L., Shiff S.I., Rigas B. Effects of non-steroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52:1996;237-245.
17. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., DuBois R. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:1998;705-716.
18. Bradford M.M. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
19. 2+] with fluorescent indicators. Methods Cell. Biol. 40 (1994) 155-181.
20. Gilman A.G., Murad F. Assay of cyclic nucleotides by receptor protein binding displacement. Methods Enzymol. 38:1974;49-61.
21. Preston S.R., Miller G.V., Primrose J.N. Bombesin-like peptides and cancer. Crit. Rev. Oncol. Hematol. 23:1996;225-238.
22. Qiao L., Kozoni V., Tsioulias G.J., Koutsos M.I., Hanif R., Shiff J., Rigas B. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta. 1258:1995;215-223.
23. Parker J., Kaplon M.K., Alvarez C.J., Krishnaswamy G. Prostglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines. Exp. Cell Res. 236:1997;321-329.
24. Konger R.L., Malaviya R., Pentland A.P. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim. Biophys. Acta. 1401:1998;221-234.
25. Yamashita T., Tsuda T., Hamamori Y., Takai Y. Possible involvement of cyclic AMP and calcium ion in prostaglandin E1-induced elevation of c-myc mRNA levels in Swiss 3T3 fibroblasts. J. Biol. Chem. 261:1986;16878-16882.
26. Danesch U., Weber P.C., Sellmayer A. Arachidonic acid increases c-fos and Egr-1 mRNA in 3T3 fibroblasts by formation of prostaglandin E2 and activation of protein kinase C. J. Biol. Chem. 269:1994;27258-27263.
27. Negishi M., Sugimoto Y., Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta. 1259:1995;109-120.